Suggestions
Michael Bolger
Founding Scientist at Simulations Plus, Inc. at Simulations Plus, Inc.
Professional Background
Michael Bolger stands as a prominent figure in the realms of pharmaceutical sciences and computational modeling, currently wearing multiple hats as the Founding Scientist at Simulations Plus, Inc., and Adjunct Full Professor of Pharmacology and Pharmaceutical Sciences at the University of Southern California. With an illustrious career spanning several decades, Michael has made substantial contributions to the development of innovative modeling and simulation software in the pharmaceutical industry, notably through his role in programming the initial version of the widely-used GastroPlus®.
With Simulations Plus, Michael collaborates with a diverse team of world-class scientists and programmers, focusing on the continued evolution of software applications that include ADMETPredictor®, GastroPlus®, DDDPlus®, and MembranePlus®. These highly specialized tools are designed to advance drug development processes and enhance the accuracy of computational predictions in pharmacokinetics and pharmacodynamics.
Beyond his pivotal role at Simulations Plus, Michael is dedicated to the academic progression of modeling and simulation methodologies. He actively engages in mentorship and partnerships with various universities through Academic and Nonprofit Research projects, fostering collaboration between industry and academia to promote scientific advancements and educational growth.
Education and Achievements
Michael Bolger's educational journey laid a robust foundation for his successful career in pharmaceutical sciences. He earned his Ph.D. in Pharmaceutical Chemistry from the prestigious University of California, San Francisco, where he delved deeply into the complexities of drug development and formulation. Before this, he obtained a Bachelor of Arts in Chemistry and Biology from UC San Diego, where he cultivated his passion for the sciences and established the groundwork for his future pursuits.
Throughout his impressive career, Michael has achieved numerous accolades that highlight both his expertise and contributions to the field. In 1996, he was honored with the distinction of becoming an AAAS Fellow, an esteemed title conferred by the American Association for the Advancement of Science, recognizing his exceptional contributions to science and technology.
In 1997, Michael's programming expertise shone brightly when he successfully developed the first version of GastroPlus®, setting a milestone in computational modeling that would benefit pharmaceutical research for years to come. His forward-thinking approach to science has continually positioned him at the forefront of pharmaceutical innovations.
Additionally, in 2001, he was appointed to an expert panel on in silico technology by the European Commission for Science and Technology (COST), underscoring his reputation as an influential thought leader in the field of predictive pharmacology. Furthermore, in 2016, he served on the NIH Scientific Advisory Committee on Alternative Toxicological Methods, guiding discussions toward the integration of more sophisticated, humane, and ethical approaches in toxicology assessments.
Contributions to the Scientific Community
Michael Bolger's influence extends beyond his professional titles and accomplishments. As an Adjunct Full Professor of Pharmacology and Pharmaceutical Sciences at the University of Southern California, he has been instrumental in educating the next generation of scientists, imparting his knowledge and experience in both pharmaceutical sciences and software development for modeling and simulation. His tenure in academia highlights his commitment to nurturing talent and contributing to ongoing research initiatives.
Furthermore, Michael's role as a mentor and collaborator facilitates the exchange of ideas and innovations between the academic sphere and industry practice. By actively engaging in partnerships, he embodies the spirit of interdisciplinary collaboration, which is crucial for advancing drug discovery and development methodologies.
Achievements
- Founding Scientist at Simulations Plus, Inc. - Michael's vision and dedication have been central to the establishment and ongoing success of Simulations Plus, a company recognized globally for its advanced simulation software.
- NIH Scientific Advisory Committee on Alternative Toxicological Methods (2016) - Contributed expert insights to enhance alternative methods in toxicity testing, reflecting his commitment to advancing ethical scientific practices.
- European Commission on in silico Technology (2001) - As part of an expert panel, he influenced the adoption of innovative technological approaches in scientific research within Europe.
- AAAS Fellow (1996) - This prestigious title highlights his impactful contributions to the scientific community, marking him as a leader in his field.
- Programming GastroPlus® (1997) - Pioneered the development of a crucial software tool that has transformed data analysis and simulation in pharmacology, including drug absorption, distribution, metabolism, excretion, and toxicity (ADMET).
To learn more about Michael Bolger and how he can provide guidance or support to your organization or academic endeavors, feel free to reach out via email at [email protected] or explore the comprehensive resources available at Simulations Plus.
title":"Michael Bolger - Expert in Pharmaceutical Sciences and Modeling Software"
tags":["Pharmaceutical Sciences","Computational Modeling","GastroPlus®","ADMETPredictor®","Academic Collaborations","Drug Development Software","Mentorship in Science","Innovative Technology","Pharmacology Education","Pharmaceutical Chemistry"],
questions":["How did Michael Bolger contribute to the development of GastroPlus® and its impact on the pharmaceutical industry?","What are the key benefits of the software programs developed by Michael Bolger and his team at Simulations Plus?","What strategies does Michael Bolger employ to foster collaboration between academia and industry in pharmaceuticals?","How has Michael Bolger's educational background influenced his career and contributions to pharmaceutical sciences?","What role does Michael Bolger see for simulation technology in the future of drug development?"]} `` ## PublicPersonData json {
